Do, Eun-Ju <br/><br/>
Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Aug 2016 
 - 1453-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/jgh.13280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Anticarcinogenic Agents--pharmacology<br/>Azoxymethane<br/>Cell Transformation, Neoplastic--drug effects<br/>Colitis--chemically induced<br/>Colon--drug effects<br/>Colorectal Neoplasms--etiology<br/>Dextran Sulfate<br/>Disease Models, Animal<br/>Gastrointestinal Agents--pharmacology<br/>Inflammation Mediators--metabolism<br/>Interleukin-6--metabolism<br/>Macrophages--drug effects<br/>Male<br/>Mesalamine--pharmacology<br/>Mice, Inbred C57BL<br/>Phenylhydrazines--pharmacology<br/>Phosphorylation<br/>Probiotics--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Time Factors<br/>bcl-2-Associated X Protein--metabolism